Database : MEDLINE
Search on : Lithiasis [Words]
References found : 5661 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 567 go to page                         

  1 / 5661 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 24972555
[Au] Autor:Cho HJ; Bae WJ; Kim SJ; Hong SH; Lee JY; Hwang TK; Choi YJ; Hwang SY; Kim SW
[Ad] Address:Department of Urology, Seoul St. Mary's Hospital, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul, 137-040, Korea.
[Ti] Title:The inhibitory effect of an ethanol extract of the spores of Lygodium japonicum on ethylene glycol-induced kidney calculi in rats.
[So] Source:Urolithiasis;42(4):309-15, 2014 Aug.
[Is] ISSN:2194-7236
[Cp] Country of publication:Germany
[La] Language:eng
[Ab] Abstract:We investigated the effect of an ethanol extract of Lygodii spora (LS) as a preventive and therapeutic agent for experimentally induced calcium oxalate nephrolithiasis with ethylene glycol (EG) in rats. Male Wistar rats were randomly divided into preventive (n = 18, for 28 days) and therapeutic (n = 24, for 42 days) groups. The preventive group was further subdivided into three groups of six rats each: preventive control, preventive lithiatic control (EG) and preventive lithiatic LS (EG + 400 mg/kg LS). Similarly, the therapeutic group was subdivided into four groups of six rats each: therapeutic control, therapeutic lithiatic control, therapeutic lithiatic untreated, and therapeutic lithiatic LS. Lithiasis was induced by adding 0.75 % EG to the drinking water of all groups except the preventive and therapeutic control groups. Preventive and therapeutic subjects also received the LS ethanol extract in drinking water at a dose of 400 mg/kg, since day 0 or day 28, respectively. At the end of the each experimental period, various biochemical parameters were measured in urine and kidney homogenates. The kidneys were subjected to histopathological analysis. The results revealed that treatment with the LS preventive protocol significantly decreased the levels of urinary calcium, oxalate and uric acid, and increased the levels of urinary citrate as compared to those in the EG control. No significant changes in the urinary parameters except oxalate and citrate levels were observed in the rats in the therapeutic protocol. In both preventive and therapeutic protocols, the extract significantly decreased kidney peroxides, renal calcium, oxalate content, and the number of kidney oxalate deposits as compared to those in the EG group. We conclude that LS is useful as a preventive and therapeutic agent against the formation of oxalate kidney stones.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1007/s00240-014-0674-z

  2 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24956667
[Au] Autor:Popkov VM; Bliumberg BI; Osnovin OV; Shatylko TV
[Ti] Title:[Application of rowatinex in the perioperative period in the extracorporeal shock wave lithotripsy].
[So] Source:Urologiia;(2):25-6, 28, 2014 Mar-Apr.
[Is] ISSN:1728-2985
[Cp] Country of publication:Russia (Federation)
[La] Language:rus
[Ab] Abstract:Despite the high efficacy and safety of ESWL used to disintegrate stones in pyelocaliceal system and upper ureter, the issue of further reduction of the risk of complications of this procedure remains unresolved. The inclusion ofphytopreparations with anti-inflammatory and lithokinetic properties in the scheme of perioperative treatment is one of the ways for prevent complications of ESWL. The effect of the drug Rowatinex on the process of discharge of calculi fragments after ESWL is evaluated. The frequency and intensity of qualitative changes of urine after appointment this drug were assessed. It is concluded that Rowatinex has positive impact on the final result of ESWL in the case of its inclusion in the complex medical treatment, which manifests in terms of reducing the time of discharge of fragments, mitigation of subjective symptoms, as well as reducing the frequency of subclinical bacteriuria and severe complications.
[Mh] MeSH terms primary: Lithotripsy
Perioperative Care/methods
Postoperative Complications/prevention & control
Terpenes/administration & dosage
Urolithiasis/therapy
[Mh] MeSH terms secundary: Adult
Female
Humans
Male
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Nm] Name of substance:0 (Terpenes); 84593-61-3 (Rowatinex)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:140624
[St] Status:MEDLINE

  3 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24119199
[Au] Autor:Carrasco J; Anglada FJ; Campos JP; Muntané J; Requena MJ; Padillo J
[Ad] Address:Department of Urology, Reina Sofia University Hospital, Cordoba, Spain.
[Ti] Title:The protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: a randomised, placebo-controlled clinical trial.
[So] Source:BJU Int;113(6):942-50, 2014 Jun.
[Is] ISSN:1464-410X
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:OBJECTIVE: To determine the efficacy of coenzyme Q10 (CoQ10) in preventing renal injury in patients with lithiasis undergoing extracorporeal shockwave lithotripsy (ESWL). PATIENTS AND METHODS: Prospective, randomised, double-blind, placebo-controlled clinical trial of 100 patients with renal lithiasis who were treated with ESWL. The patients were distributed randomly into two groups receiving either placebo or CoQ10 (200 mg/day), a powerful antioxidant with vasoactive properties, orally administered during the week before ESWL and for 1 week after. Renal dysfunction markers, vasoactive hormones, oxidative stress, plasma levels of several interleukins and vascular resistance index (VRI) using Doppler ultrasound were evaluated the week before ESWL, 2 h before ESWL and at 2 h, 24 h and 7 days after ESWL. RESULTS: There was a significant increase in glomerular filtration (P = 0.013), as well as a decrease in the albumin/creatinine ratio and the ß2 -microglobulin level (P = 0.02) after 1 week of treatment in the CoQ10 group. These changes were maintained at the follow-up after ESWL. The administration of CoQ10 was associated with improvement in vasoactive hormone parameters, VRI and interleukin levels. These improvements were maintained until the end of the follow-up period. However, the administration of CoQ10 was not associated with significant changes in the oxidative stress parameters. CONCLUSION: Our results indicate that CoQ10 administration improves renal function and vasoactive and inflammation parameter values, allowing for preconditioning before the tissue insult caused by ESWL.
[Mh] MeSH terms primary: Kidney/injuries
Lithotripsy/adverse effects
Ubiquinone/analogs & derivatives
Vitamins/therapeutic use
[Mh] MeSH terms secundary: Double-Blind Method
Female
Humans
Kidney Calculi/therapy
Male
Middle Aged
Prospective Studies
Ubiquinone/therapeutic use
Wounds and Injuries/prevention & control
[Pt] Publication type:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Nm] Name of substance:0 (Vitamins); 1339-63-5 (Ubiquinone); 303-98-0 (coenzyme Q10)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:140609
[St] Status:MEDLINE
[do] DOI:10.1111/bju.12485

  4 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24209533
[Au] Autor:Assimos DG
[Ti] Title:Re: Contemporary volume-outcome relationships for percutaneous nephrolithotomy: results from the nationwide inpatient sample.
[So] Source:J Urol;190(6):2124, 2013 Dec.
[Is] ISSN:1527-3792
[Cp] Country of publication:United States
[La] Language:eng
[Mh] MeSH terms primary: Hospitals, High-Volume
Hospitals, Low-Volume
Inpatients
Nephrostomy, Percutaneous
Outcome and Process Assessment (Health Care)
Urolithiasis/surgery
[Mh] MeSH terms secundary: Female
Humans
Male
[Pt] Publication type:COMMENT; JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:131111
[St] Status:MEDLINE

  5 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 24039374
[Au] Autor:Bai XL; Chen YW; Zhang Q; Ye LY; Xu YL; Wang L; Cao CH; Gao SL; Khoodoruth MA; Ramjaun BZ; Dong AQ; Liang TB
[Ad] Address:Xue-Li Bai, Yi-Wen Chen, Qi Zhang, Long-Yun Ye, Yuan-Liang Xu, Liang Wang, Chun-Hui Cao, Shun-Liang Gao, Mohamed Adil Shah Khoodoruth, Bibi Zaina Ramjaun, Ting-Bo Liang, Department of Hepatobiliary-Pancreatic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang Province, China.
[Ti] Title:Acute iatrogenic Budd-Chiari syndrome following hepatectomy for hepatolithiasis: a report of two cases.
[So] Source:World J Gastroenterol;19(34):5763-8, 2013 Sep 14.
[Is] ISSN:2219-2840
[Cp] Country of publication:China
[La] Language:eng
[Ab] Abstract:Budd-Chiari syndrome (BCS) is defined as hepatic venous outflow obstruction at any level from the small hepatic veins to the junction of the inferior vena cava (IVC) and the right atrium, regardless of the cause of obstruction. We present two cases of acute iatrogenic BCS and our clinical management of these cases. The first case was a 43-year-old woman who developed acute BCS following the implantation of an IVC stent for the correction of stenosis in the IVC after hepatectomy for hepatolithiasis. The second case was a 61-year-old woman with complete obstruction of the outflow of hepatic veins during bilateral hepatectomy for hepatolithiasis. Acute iatrogenic BCS should be considered a rare complication following hepatectomy for hepatolithiasis. Awareness of potential hepatic outflow obstructions and timely management are critical to avoid poor outcomes when performing hepatectomy for hepatolithiasis.
[Mh] MeSH terms primary: Budd-Chiari Syndrome/etiology
Hepatectomy/adverse effects
[Mh] MeSH terms secundary: Adult
Female
Humans
Iatrogenic Disease
Lithiasis/surgery
Liver Diseases/surgery
Middle Aged
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:130916
[St] Status:MEDLINE
[do] DOI:10.3748/wjg.v19.i34.5763

  6 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23348148
[Au] Autor:Abhishek; Kumar J; Mandhani A; Srivastava A; Kapoor R; Ansari MS
[Ad] Address:Department of Urology and Renal transplantation, Sanjay Gandhi Postgraduate Institute of Medical Science, Raebreali Road, Lucknow 226014, U.P, India.
[Ti] Title:Pediatric urolithiasis: experience from a tertiary referral center.
[So] Source:J Pediatr Urol;9(6 Pt A):825-30, 2013 Dec.
[Is] ISSN:1873-4898
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:OBJECTIVE: Pediatric urolithiasis can cause significant morbidity and damage to the kidney, or even renal failure. We review our experience of the management of urolithiasis in pediatric patients at a tertiary referral center. PATIENTS AND METHODS: We reviewed medical records of all children with urolithiasis who were diagnosed and managed at our center from August 2003 to October 2011. Management was planned according to stone burden and location. We noted and statistically analysed data about age, sex, stone burden, clinical features, management, metabolic abnormalities and recurrence. RESULTS: There were 325 children with 378 stone sites. Age range was 3-17 (mean 8) years. The male to female ratio was 3:1. Most common presentation was abdominal pain in 257 children (79%), and the most common stone site was kidney in 215 (57%). Twenty-four (7%) children (stone burden ≤3 mm) were managed conservatively, while the rest received some form of intervention. Metabolic workup could be done in 154 (47%) children. A metabolic abnormality was seen in 67 (43%) children, normocalcemic hypercalciuria being the most common. Recurrence of urolithiasis was seen in 78 (24%) children after a mean follow-up of 3.2 (1-6) years, and was more common in those who had a metabolic abnormality or in whom small residual fragments were left in situ. CONCLUSIONS: Availability of smaller instruments has led to safer use of percutaneous endoscopy and ureteroscopy in children, with results comparable to those in adults and an acceptable complication rate. The presence of a metabolic abnormality is quite common and is a cause of recurrence.
[Mh] MeSH terms primary: Tertiary Care Centers
Urolithiasis/surgery
Urolithiasis/therapy
[Mh] MeSH terms secundary: Abdominal Pain/epidemiology
Adolescent
Child
Child, Preschool
Female
Hematuria/epidemiology
Humans
Lithotripsy
Male
Metabolic Diseases/epidemiology
Morbidity
Recurrence
Retrospective Studies
Risk Factors
Severity of Illness Index
Ureteroscopy
Urinary Tract Infections/epidemiology
Urolithiasis/epidemiology
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131118
[St] Status:MEDLINE

  7 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23876586
[Au] Autor:Toepfer NJ; Baylor K; Henry Y; Simmons J; Berger PB
[Ad] Address:Department of Urology, Cardiovascular Center for Clinical Research, Geisinger Clinic, Danville, PA. Electronic address: njtoepfer@geisinger.edu.
[Ti] Title:The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy.
[So] Source:Urology;82(4):773-9, 2013 Oct.
[Is] ISSN:1527-9995
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:OBJECTIVE: To determine if there is any difference in the clinical outcome for patients receiving aspirin, clopidogrel, and warfarin undergoing ureteroscopy and laser lithotripsy for urolithiasis compared with patients on no antithrombotic medication. METHODS: We retrospectively reviewed patients who underwent ureteroscopy for urolithaisis from July 1, 2005 to October 1, 2010. If patients continued aspirin, clopidogrel, or warfarin within 48 hours of surgery, they were considered to be on antithrombotic therapy. Patients not on these medications or those who discontinued the medications atleast 5 days before surgery comprised the control group. Six hundred forty-six patients met our inclusion criteria for analysis including 137 on aspirin alone, 17 on clopidogrel, 22 on warfarin, and 470 in the control group. RESULTS: Patients on antiplatelet and anticoagulants were older and were more likely to have risk factors for thromboembolism. When comparing patients on aspirin, clopidogrel, or warfarin with patients not on these medications, there was no difference in bleeding complications or need for an unplanned repeat ureteroscopy. There was also no difference in complications within 30 days of surgery. CONCLUSION: Among patients undergoing elective ureteroscopy and laser lithotripsy on the antithrombotic medications aspirin, clopidogrel, and warfarin, the procedure was as successful, and complications were not increased, compared with patients on no antithrombotic medications.
[Mh] MeSH terms primary: Anticoagulants/therapeutic use
Aspirin/therapeutic use
Lithotripsy, Laser
Platelet Aggregation Inhibitors/therapeutic use
Ticlopidine/analogs & derivatives
Ureteroscopy
Urolithiasis/diagnosis
Warfarin/therapeutic use
[Mh] MeSH terms secundary: Aged
Female
Humans
Male
Middle Aged
Retrospective Studies
Ticlopidine/therapeutic use
Treatment Outcome
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Anticoagulants); 0 (Platelet Aggregation Inhibitors); 5Q7ZVV76EI (Warfarin); A74586SNO7 (clopidogrel); OM90ZUW7M1 (Ticlopidine); R16CO5Y76E (Aspirin)
[Em] Entry month:1311
[Cu] Class update date: 140715
[Lr] Last revision date:140715
[Js] Journal subset:IM
[Da] Date of entry for processing:130930
[St] Status:MEDLINE

  8 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25017280
[Au] Autor:Lee CC; Chao AS; Chang YL; Peng HH; Wang TH; Chao A
[Ad] Address:Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan....
[Ti] Title:Acute pancreatitis secondary to primary hyperparathyroidism in a postpartum patient: A case report and literature review.
[So] Source:Taiwan J Obstet Gynecol;53(2):252-5, 2014 Jun.
[Is] ISSN:1875-6263
[Cp] Country of publication:China (Republic : 1949- )
[La] Language:eng
[Ab] Abstract:OBJECTIVE: Primary hyperparathyroidism (PHPT) is a rare clinical entity in reproductive women. Unusual hypercalcemia causing pancreatitis in the peripartum period carries significant morbidity to both the fetus and the mother. CASE REPORT: A 38-year-old woman developed a morbid course of intractable intra-abdominal abscess by pancreatitis, hydronephrosis by renal lithiasis, and unusual neurological presentations soon after delivery. Serial serum calcium level and imaging studies lead to the final diagnosis of PHPT due to a parathyroid adenoma. Data on 14 patients who suffered from pancreatitis due to hyperparathyroidism were collected from a MEDLINE search. The reasons for delayed diagnosis and literature review of acute pancreatitis in PHPT are discussed. CONCLUSION: Hypercalcemia can be masked during pregnancy and in severe pancreatitis, as was detected in about half of the case series. Clinicians should have a high level of suspicion of parathyroid adenoma in cases with a profound pancreatitis. Timely diagnosis and early therapeutic intervention are important to resolve complications and improve the outcomes of mothers and fetuses.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[St] Status:In-Data-Review

  9 / 5661 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24183089
[Au] Autor:Doizi S; Letendre J; Bensalah K; Traxer O
[Ad] Address:Service d'urologie, université Pierre et Marie Curie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France. Electronic address: steeve.doizi@gmail.com.
[Ti] Title:Prise en charge pharmacologique de la lithiase urinaire. [Pharmacologic treatment of urinary stones].
[So] Source:Prog Urol;23(15):1312-7, 2013 Nov.
[Is] ISSN:1166-7087
[Cp] Country of publication:France
[La] Language:fre
[Ab] Abstract:AIM: To describe the pharmacotherapy of urinary lithiasis. METHOD: Results of a literature search (PubMed) was summarized by an experts board. RESULTS: The incidence of urolithiasis constantly increases in industrialized countries and its prevalence in France is estimated around 10% in the general population. Due to its high recurrence rate urolithiasis is a public health concern. Significant progresses in both surgery and pharmacotherapy during the last thirty years markedly improve prognostic of high recurrence risk patients. CONCLUSION: Better understanding of the physiologic disturbances involve in stone formation has allowed to identify at lest one factor in every subset of patient in which diet and pharmacotherapy will reduce the recurrence rate. In this review are discussed treatments of the crisis as well as the metabolic treatment.
[Mh] MeSH terms primary: Urinary Calculi/drug therapy
[Mh] MeSH terms secundary: Anti-Bacterial Agents/therapeutic use
Chelating Agents/therapeutic use
Citric Acid/therapeutic use
Humans
Hydrogen-Ion Concentration
Methionine/therapeutic use
Sodium Chloride Symporter Inhibitors/therapeutic use
Urinary Calculi/etiology
Urinary Tract Infections/complications
Urine/chemistry
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:0 (Anti-Bacterial Agents); 0 (Chelating Agents); 0 (Sodium Chloride Symporter Inhibitors); 2968PHW8QP (Citric Acid); AE28F7PNPL (Methionine)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131104
[St] Status:MEDLINE

  10 / 5661 MEDLINE  
              first record previous record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 24086562
[Au] Autor:Sharma A; Prasongwattana V; Cha'on U; Selmi C; Hipkaeo W; Boonnate P; Pethlert S; Titipungul T; Intarawichian P; Waraasawapati S; Puapiroj A; Sitprija V; Reungjui S
[Ad] Address:Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
[Ti] Title:Monosodium glutamate (MSG) consumption is associated with urolithiasis and urinary tract obstruction in rats.
[So] Source:PLoS One;8(9):e75546, 2013.
[Is] ISSN:1932-6203
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: The peritoneal injection of monosodium glutamate (MSG) can induce kidney injury in adult rats but the effects of long-term oral intake have not been determined. METHODS: We investigated the kidney histology and function in adult male Wistar rats that were fed ad libitum with a standard rat chow pellet and water with or without the addition of 2 mg/g body weight MSG/day in drinking water (n=10 per group). Both MSG-treated and control animals were sacrificed after 9 months when renal function parameters, blood and urine electrolytes, and tissue histopathology were determined. RESULTS: MSG-treated rats were more prone to kidney stone formation, as represented by the alkaline urine and significantly higher activity product of calcium phosphate. Accordingly, 3/10 MSG-treated rats developed kidney stones over 9 months versus none of the control animals. Further, 2/10 MSG-treated rats but none (0/10) of the controls manifested hydronephrosis. MSG-treated rats had significantly higher levels of serum creatinine and potassium including urine output volume, urinary excretion sodium and citrate compared to controls. In contrast, MSG-treated rats had significantly lower ammonium and magnesium urinary excretion. CONCLUSION: Oral MSG consumption appears to cause alkaline urine and may increase the risks of kidney stones with hydronephrosis in rats. Similar effects in humans must be verified by dedicated studies.
[Mh] MeSH terms primary: Sodium Glutamate/adverse effects
Urolithiasis/etiology
Urologic Diseases/etiology
[Mh] MeSH terms secundary: Animals
Eating/physiology
Electrolytes/blood
Electrolytes/urine
Kidney/pathology
Kidney Calculi/blood
Kidney Calculi/etiology
Kidney Calculi/pathology
Kidney Calculi/urine
Kidney Function Tests/methods
Male
Rats
Rats, Wistar
Sodium/metabolism
Urolithiasis/blood
Urolithiasis/pathology
Urolithiasis/urine
Urologic Diseases/blood
Urologic Diseases/pathology
Urologic Diseases/urine
Water/metabolism
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Electrolytes); 059QF0KO0R (Water); 9NEZ333N27 (Sodium); W81N5U6R6U (Sodium Glutamate)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131002
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0075546


page 1 of 567 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information